F-18 fluoro deoxyglucose SPECT for assessment of myocardial viability

Journal of Nuclear Cardiology

Volumn 7, Issue 4, 2000, Pages 382-387

  Fitzgerald, James ^a   Parker, J Anthony ^a   Danias, Peter G ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOBUTAMINE; FLUORODEOXYGLUCOSE F 18; GLUCOSE; INSULIN; TECHNETIUM 99M; THALLIUM 201;

ARTICLE; CARDIOMYOPATHY; COLLIMATOR; COMPARATIVE STUDY; COMPUTER PROGRAM; CONTRAST ENHANCEMENT; CORONARY ARTERY BLOOD FLOW; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE METABOLISM; HEART MUSCLE PERFUSION; HUMAN; IMAGE QUALITY; ISCHEMIC HEART DISEASE; MYOCARDIAL HIBERNATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SCINTIANGIOCARDIOGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STRESS ECHOCARDIOGRAPHY;

EID: 0033841890     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1067/mnc.2000.107821     Document Type: Article

References (34)

1. Post-extrasystolic potentiation of ischemic myocardium by atrial stimulation
2. A perspective on the three large multicenter randomized clinical trials of coronary bypass surgery for chronic stable angina
3. Results of coronary artery surgery in patients with poor left ventricular function (CASS)
4. Effect of myocardial viability assessed by technetium-99m-sestamibi SPECT and fluorine-18-FDG PET on clinical outcome in coronary artery disease
5. Improved regional ventricular function after successful surgical revascularization
6. The effect of coronary artery bypass grafting on left ventricular systolic function at rest: Evidence for preoperative subclinical myocardial ischemia
7. Prediction by postexercise fluoro-18 deoxyglucose positron emission tomography of improvement in exercise capacity after revascularization
8. Chronic myocardial hibernation in humans. From bedside to bench
9. Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy
10. Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography
11. Long-term survival of patients with coronary artery disease and left ventricular dysfunction: Implications for the role of myocardial viability assessment in management decisions
12. Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction
13. Results of revascularization in patients with severe left ventricular dysfunction
14. Preoperative positron emission tomographic viability assessment and perioperative and postoperative risk in patients with advanced ischemic heart disease
15. Hibernating myocardium
16. Nonuniformity in myocardial accumulation of fluorine-18-fluorodeoxyglucose in normal fasted humans
17. Present assessment of myocardial viability by nuclear imaging
18. Metabolic trapping as a principle of radiopharmaceutical design: Some factors responsible for the biodistribution of [18F] 2-deoxy-2-fluoro-D-glucose
19. Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron-emission tomography scanning: Potential for error in interpretation
20. Prediction of improvement of contractile function in patients with ischemic ventricular dysfunction after revascularization by fluorine-18 fluorodeoxyglucose single-photon emission computed tomography
21. Direct comparison of fluorine-18-FDG SPECT, fluorine-18-FDG PET and rest thallium-201 SPECT for detection of myocardial viability
22. Myocardial viability studies using fluorine-18-FDG SPECT: A comparison with fluorine-18-FDG PET
23. FDG-SPECT: Correlation with FDG-PET
24. Validity of 18F-fluorodeoxyglucose imaging with a dual-head coincidence gamma camera for detection of myocardial viability
25. Investigation of [18F]2-fluoro-2-deoxyglucose for the measure of myocardial glucose metabolism
26. Quantitative evaluation of regional substrate metabolism in the human heart by positron emission tomography
27. Fluorodeoxyglucose imaging to assess myocardial viability: PET, SPECT or gamma camera coincidence imaging?
28. Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease: Comparison of pooled data
29. Comparison of myocardial uptake of fluorine-18-fluorodeoxyglucose imaged with PET and SPECT in dyssynergic myocardium
30. Prediction of recovery of myocardial dysfunction after revascularization. Comparison of fluorine-18 fluorodeoxyglucose/thallium-201 SPECT, thallium-201 stress-reinjection SPECT and dobutamine echocardiography
31. [18F]fluorodeoxyglucose single photon emission computed tomography: Can it replace PET and thallium SPECT for the assessment of myocardial viability?
32. Comparative performance of gated perfusion SPECT wall thickening, delayed thallium uptake, and F-18 fluorodeoxyglucose SPECT in detecting myocardial viability
33. Agreement and disagreement between ″metabolic viability″ and ″contractile reserve″ in akinetic myocardium